NLRP3 and breast carcinoma: In breast cancer, the NLRP3 inflammasome and IL‐1β production induce the infiltration of myeloid cells, such as tumor‐associated macrophages (TAMs) and myeloid‐derived suppressor cells, forming an inflammatory microenvironment and thus promoting breast cancer progression.76